Skip to main content

Summary

for people ages 60–89 (full criteria)
at San Francisco, California and other locations
study started
estimated completion:

Description

Summary

The study is designed to examine the relationship between imaging results detected on a 18F-AV-1451 PET scan and pathology found at autopsy within six months of imaging.

Official Title

A High Resolution Autopsy Study Evaluating the Relationship of 18F-AV-1451 PET Imaging and Tau Pathology

Keywords

Alzheimer's Disease Alzheimer Disease

Eligibility

You can join if…

Open to people ages 60–89

  • Projected life expectancy ≤ 6 months

You CAN'T join if...

  • Primary brain tumor, known metastases to the brain, central nervous system lymphoma
  • Major, focal structural brain lesion
  • Aggressively being treated with life sustaining measures
  • Clinically significant infectious disease
  • History of risk factors for Torsades de Pointes or are currently taking medication known to cause QT prolongation
  • Have received or participated in a trial with investigational medications in the past 30 days
  • Females of childbearing potential who are pregnant or not using adequate contraception

Locations

  • University of California, San Francisco
    San Francisco, California, 94121, United States
  • Banner Alzheimer's Institute
    Phoenix, Arizona, 85006, United States

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Avid Radiopharmaceuticals
ID
NCT02350634
Phase
Phase 1
Study Type
Interventional
Last Updated
November 28, 2017